SIGA Technologies (NASDAQ:SIGA) Shares Down 5.9%

SIGA Technologies, Inc. (NASDAQ:SIGA)’s share price traded down 5.9% on Tuesday . The company traded as low as $7.86 and last traded at $7.86. 228,849 shares were traded during mid-day trading, a decline of 62% from the average session volume of 605,176 shares. The stock had previously closed at $8.35.

SIGA Technologies Price Performance

The firm has a 50-day simple moving average of $5.69 and a 200 day simple moving average of $5.42. The company has a market capitalization of $608.55 million, a PE ratio of 9.01 and a beta of 0.85.

SIGA Technologies Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, April 11th. Stockholders of record on Tuesday, March 26th will be given a dividend of $0.60 per share. This is a positive change from SIGA Technologies’s previous dividend of $0.45. The ex-dividend date is Monday, March 25th.

Institutional Trading of SIGA Technologies

Hedge funds and other institutional investors have recently modified their holdings of the business. Point72 Middle East FZE purchased a new stake in shares of SIGA Technologies during the fourth quarter worth about $27,000. UBS Group AG increased its holdings in SIGA Technologies by 30.3% in the second quarter. UBS Group AG now owns 4,596 shares of the company’s stock valued at $53,000 after buying an additional 1,070 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in SIGA Technologies by 200.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,955 shares of the company’s stock valued at $45,000 after buying an additional 5,309 shares during the last quarter. China Universal Asset Management Co. Ltd. increased its holdings in SIGA Technologies by 351.7% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 8,225 shares of the company’s stock valued at $46,000 after buying an additional 6,404 shares during the last quarter. Finally, Steward Partners Investment Solutions LLC bought a new stake in SIGA Technologies in the fourth quarter valued at about $58,000. 55.40% of the stock is owned by hedge funds and other institutional investors.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.